Form 4: Eli Lilly Executive Patrik Jonsson Reports Stock and Restricted Stock Unit Transactions
SEC Form 4 Filing
EVP & President of Eli Lilly, Patrik Jonsson, reports acquisition of common stock and restricted stock units.
Summary
- Patrik Jonsson, EVP & President at Eli Lilly & Co, filed a Form 4 detailing changes in beneficial ownership.
- On February 10, 2025, Jonsson acquired 7,170.498 shares of common stock at a price of $868.88 per share.
- Following the transaction, Jonsson directly owns 53,650.639 shares of common stock.
- Jonsson also indirectly owns 574.5 shares of common stock through a 401(k).
- Additionally, Jonsson acquired 3,930 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable on February 1, 2026, and expiring on February 1, 2026.
- Following the transaction, Jonsson directly owns 3,930 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The acquisition of shares by an executive could be interpreted as a positive signal about the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on market sentiment.
Comparison to Industry Standards
- Executive compensation packages often include stock and restricted stock units to align management's interests with those of shareholders.
- The specific amounts and vesting schedules for these awards vary widely across the pharmaceutical industry, depending on company size, performance, and individual executive agreements.
- Comparing Jonsson's holdings and recent transactions to those of executives at comparable companies like Pfizer (PFE) or Merck (MRK) would provide a broader context for assessing the significance of this filing.
Stakeholder Impact
- The transactions could influence shareholder perception of the company's leadership confidence.
- The acquisition of shares by an executive may positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of transaction for common stock and restricted stock units acquisition. |
| 02/01/2026 | Date restricted stock units become exercisable and expire. |
| 02/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.